INFRAFONTIER Research Infrastructure will organize a course to deepen the knowledge about the morphological and anatomical aspects of mice models. The course will consist in two modules: the first one devoted to the anatomy and imaging will be held in Barcelona on 18th-23th June 2018, the second module will be dedicated to the histology and
The 11th edition of the “Positive Psychology and interconnection: real and virtual communities” Days will take place on 15th and 16th June, 2018 at the University of Bari, and it will be focused on the perspectives and the potentialities of the virtual community as facilitator rather than obstacle for the real community. Moreover, the experts
The European Medicines Agency (EMA) has recently published a question-and-answer document to dispel any doubt on the meaning of orphan designation and other aspects related to orphan medicines Regulation in EU. The EU legislation foresees giving orphan designation for substances that could be used for treating, preventing or diagnosing a rare and serious condition. Orphan
The project ID-EPTRI (European Paediatric Translational Research Infrastructure), coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche with the aim to design the framework of a new Paediatric Research Infrastructure and involving TEDDY Network as third party, foresees among its activities, the development of an ad hoc survey for outlining the current European scientific and technological
The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), through its Working Group for preparedness in paediatric clinical trials, is performing different actions aimed to facilitate the conduct of paediatric clinical studies focusing on identification and resolution of barriers to drug development in children. TEDDY Network is member of this Working Group
The Working Groups 3 (Establish collaboration between Enpr-EMA networks and industry) and 5 (Sharing good practices within Enpr-EMA and with industry) of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) has launched an initiative to try to enhance communication between industry and networks. For this purpose, the experts participating to this
The European Paediatric Formulation Initiative (EUFPI) in partnership with International for Pharmaceutical Technology will organize its 10th Conference entitled “Formulating better medicines for children” on 11-13 September 2018 at the University College London School of Pharmacy. The event will foresee the succession of workshops and Plenary Lecturers that will allow to deepen some fundamental themes
The European Federation for Pharmaceutical Sciences (EUFEPS) held its annual meeting on 24-26 May 2018 in Athens in collaboration with Conference Co-chair Prof. Panos Macheras supported by University of Athens and with parallel tracks organized by EUFPES Networks. The theme of the event was “Crossing Barriers for Future Medicines” and covered some interesting topics such
A new effort to speed up paediatric drug development and arise awareness on the importance of clinical and pre-clinical paediatric trials has been done by the Food and Drugs Administration (FDA) that published a new draft guidance recommending early, pre-approval trials in pediatrics for systemic dermatitis drugs. This guidance addresses FDA’s current thinking about the
The Working Party on the protection of individuals with regard to the processing of personal data is an independent European advisory group on data protection and privacy that was set up under Article 29 of Directive 95/46/EC. On 10 April 2018, the Working Party adopted the revised Guidelines on consent under Regulation 2016/679 that provide